Syndax


Syndax Pharmaceuticals, Inc (Syndax) is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company’s product candidate, entinostat, which was granted Breakthrough The...

Industries

Employees

51-200

Links


Org chart

Collapse
Peter Ordentlich
Chief Scientific Officer and Founder
Anjali Ganguli
Chief Business Officer
Kevin McManus
Chief People Officer
Nate Ide
Senior Vice President, Market Access And Global Value
Steven Closter
Chief Commercial Officer (cco)
Norman Nagl
Vice President, Medical Affairs
Luke J. Albrecht
General Counsel

Board & advisors